(19)
(11) EP 1 734 971 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.02.2012 Bulletin 2012/09

(45) Mention of the grant of the patent:
02.11.2011 Bulletin 2011/44

(21) Application number: 04750134.1

(22) Date of filing: 15.04.2004
(51) International Patent Classification (IPC): 
A61K 31/573(2006.01)
C07K 7/00(2006.01)
 C07K 1/00(2006.01)
C07K 14/00(2006.01)
(86) International application number:
PCT/US2004/011547
(87) International publication number:
WO 2005/110425 (24.11.2005 Gazette 2005/47)

(54)

POLYMER-BASED SUSTAINED RELEASE DEVICE

VORRICHTUNG AUF POLYMERBASIS MIT VERZÖGERTER FREISETZUNG

DISPOSITIF À LIBÉRATION CONTRÔLÉE À BASE DE POLYMÈRE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(43) Date of publication of application:
27.12.2006 Bulletin 2006/52

(60) Divisional application:
11180259.1 / 2409707

(73) Proprietors:
  • Alkermes Pharma Ireland Limited
    County Westmeath (IE)
  • Amylin Pharmaceuticals, Inc.
    San Diego, CA 92121 (US)

(72) Inventors:
  • WRIGHT, Steven, G.
    Madeira, OH 45243 (US)
  • CHRISTENSON, Troy
    Mason, OH 45040 (US)
  • YEOH, Thean, Y.
    Foxboro, MA 02035 (US)
  • RICKEY, Michael, E.
    Morrow, OH 45142 (US)
  • HOTZ, Joyce, M.
    Cincinnati, OH 45249 (US)
  • KUMAR, Rajesh
    Marlborough, MA 01752 (US)
  • COSTANTINO, Henry, R.
    Woodinville, WA 98021 (US)
  • SMITH, Christine
    San Diego, California 92121  (US)
  • LOKENSGARD, David
    San Diego, California 92121 (US)
  • ONG, John
    San Diego, California 92121 (US)

(74) Representative: Chapman, Paul William et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)


(56) References cited: : 
WO-A-97/31943
WO-A-2004/034975
US-A1- 2003 003 074
US-B1- 6 190 702
 WO-A-03/020245
US-A- 5 589 167
US-A1- 2004 121 009
US-B1- 6 465 425
   
  • SZAYNA M. ET AL.: 'Exendin-4 decelerates food intake, wieght gain, and fat deposition in zucker rats' ENDOCRINOLOGY vol. 141, no. 6, 2000, pages 1936 - 1941, XP002904751
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).